Literature DB >> 2028432

Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study.

C Kelly1, P Gardiner, B Pal, I Griffiths.   

Abstract

Clinical and radiological assessment of 100 patients (97 female) with primary Sjögren's syndrome was performed within six months of diagnosis in conjunction with spirometry and measurement of transfer factor for carbon monoxide (TLCO). This was repeated in an unselected subgroup of 30 patients after a mean interval of four years. On initial assessment, 43 patients had symptoms of lung disease and 10 had related physical signs; the chest radiograph was abnormal in five. There was a significant reduction (more than 2 standardised residuals) in forced expiratory volume in one second (FEV1), vital capacity (VC), and TLCO in 14, 12, and 10 patients, 24 patients overall having a significant reduction in one or more of these measures. There was a strong relation between reduction in lung function and both pulmonary symptoms and a lip biopsy specimen positive for Sjögren's syndrome. Lung function at the initial assessment in the 30 patients who were restudied was almost identical to that of the group as a whole. Seventeen now had symptoms and nine had related physical signs. The chest radiograph was abnormal in four patients. More patients had a significant reduction in FEV1, VC, and TLCO. Lung disease is sometimes an early feature of primary Sjögren's syndrome and may progress over a relatively short period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2028432      PMCID: PMC463025          DOI: 10.1136/thx.46.3.180

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Sjogren's syndrome: report of a fatal case with pulmonary and renal lesions.

Authors:  U G BUCHER; L REID
Journal:  Br J Dis Chest       Date:  1959-07

2.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  C V Strimlan; E C Rosenow; M B Divertie; E G Harrison
Journal:  Chest       Date:  1976-09       Impact factor: 9.410

3.  Sjögren's syndrome. Proposed criteria for classification.

Authors:  R I Fox; C A Robinson; J G Curd; F Kozin; F V Howell
Journal:  Arthritis Rheum       Date:  1986-05

4.  Xerotrachea and interstitial lung disease in primary Sjogren's syndrome.

Authors:  S H Constantopoulos; A A Drosos; P J Maddison; H M Moutsopoulos
Journal:  Respiration       Date:  1984       Impact factor: 3.580

5.  Pulmonary function in patients with primary Sjögren's syndrome.

Authors:  P Oxholm; A Bundgaard; E Birk Madsen; R Manthorpe; F Vejlø Rasmussen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

6.  Lymphocytic interstitial pneumonitis. Review of 13 cases.

Authors:  C V Strimlan; E C Rosenow; L H Weiland; L R Brown
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

7.  Pulmonary function abnormalities in Sjögren's syndrome and the sicca complex.

Authors:  I Segal; G Fink; I Machtey; V Gura; S A Spitzer
Journal:  Thorax       Date:  1981-04       Impact factor: 9.139

8.  Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome.

Authors:  C Vitali; A Tavoni; G Viegi; E Begliomini; A Agnesi; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

9.  Chronic obstructive airway disease in patients with Sjögren's syndrome.

Authors:  H H Newball; S A Brahim
Journal:  Am Rev Respir Dis       Date:  1977-02

10.  Quantitation and detection of isotypes of anti-SS-B antibodies by ELISA and Farr assays using affinity purified antigens. An approach to the investigation of Sjögren's syndrome and systemic lupus erythematosus.

Authors:  P J Venables; P J Charles; R R Buchanan; T Yi; P A Mumford; L Schrieber; G R Room; R N Maini
Journal:  Arthritis Rheum       Date:  1983-02
View more
  10 in total

1.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis.

Authors:  W U Hassan; N P Keaney; C D Holland; C A Kelly
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

3.  The relationship between rheumatoid arthritis and bronchiectasis.

Authors:  C Kelly; P Gardiner
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 4.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

5.  Bronchiectasis and rheumatoid arthritis: a clinical study.

Authors:  M J McMahon; D R Swinson; S Shettar; R Wolstenholme; C Chattopadhyay; P Smith; P Johns; N H Crosby
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

6.  CXCR2 May Serve as a Useful Index of Disease Activity in Interstitial Lung Disease Associated With Primary Sjögren's Syndrome.

Authors:  Xiaofang Zhu; Saisai Lu; Lixia Zhu; Mengjiao Yu; Tingting Wei; Xiaochun Zhu; Dan Chen; Chengshui Chen
Journal:  Front Mol Biosci       Date:  2021-05-13

7.  Eight-year follow-up of airway hyperresponsiveness in patients with primary Sjögren's syndrome.

Authors:  Dora Ludviksdottir; Sigridur Th Valtysdottir; Hans Hedenström; Roger Hällgren; Björn Gudbjörnsson
Journal:  Ups J Med Sci       Date:  2016-11-16       Impact factor: 2.384

Review 8.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

9.  Interstitial lung disease in Primary Sjögren's syndrome.

Authors:  Wei Lin; Zhifei Xin; Jianlong Zhang; Ning Liu; Xiuying Ren; Meilu Liu; Yashuang Su; Yixuan Liu; Liu Yang; Shaoying Guo; Yupeng Yang; Yang Li; Jingjing Cao; Xiaoran Ning; Jingjing Li; He Xue; Nannan Niu; Yingmin Chen; Fang Li; Lijun Sun; Xiaopeng Zhang; Fengxiao Zhang; Wen Zhang
Journal:  BMC Pulm Med       Date:  2022-02-27       Impact factor: 3.317

10.  Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.

Authors:  Augustine S Lee; R Hal Scofield; Katherine Morland Hammitt; Nishant Gupta; Donald E Thomas; Teng Moua; Kamonpun Ussavarungsi; E William St Clair; Richard Meehan; Kieron Dunleavy; Matt Makara; Steven E Carsons; Nancy L Carteron
Journal:  Chest       Date:  2020-10-16       Impact factor: 9.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.